Blackwell Futura Media Services designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit TM . Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Co
MRI-guided ablation of breast cancer: Where do we stand today?
✍ Scribed by Emily L. Postma; Richard van Hillegersberg; Bruce L. Daniel; Laura G. Merckel; Helena M. Verkooijen; Maurice A.A.J. van den Bosch
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 842 KB
- Volume
- 34
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The treatment of patients with localized breast cancer has changed considerably over the past few decades. The next challenge is to use image‐guided minimally invasive tumor ablation techniques. The fact that MRI is the most accurate imaging modality for visualization and delineation of breast tumor margins in three dimensions and provides MRI‐based temperature mapping, makes it particularly applicable for monitoring during minimally invasive ablation techniques. The overall result of the studies performed on MRI‐guided minimally invasive tumor ablation studies are varying, with reported total tumor ablation rates ranging between 20% and 100%. Strict selection of patients, consensus on the treatment zone margin and optimization of MR‐imaging, should make MRI‐guided breast cancer tumor ablation a useful tool in clinical practice. J. Magn. Reson. Imaging 2011;. © 2011 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract This study was designed to demonstrate the feasibility of MRI‐guided radiofrequency ablation (RFA) of breast cancer. A total of three women diagnosed with invasive ductal breast cancer were treated with percutaneous MRI‐guided RFA, according to a treat and resect protocol, in our hospit
Breast cancer is the most common invasive cancer in women worldwide and the leading cause of death in US women in mid-life. Treatment has adverse effects, adding to the importance of finding modifiable risk factors. At the invitation of Susan G. Komen for the Cure, we reviewed studies of breast canc